Ana M. Gonzalez Ramos | Gender and Health | Best Researcher Award

Dr. Ana M. Gonzalez Ramos | Gender and Health | Best Researcher Award

Instituto de Estudios Sociales Avanzados – Consejo Superior de Investigaciones Científicas | Spain

Dr. Ana M. Gonzalez Ramos is an accomplished sociologist whose research illuminates the intersections of gender, technology, health, and professional careers within contemporary societies. Her work integrates gender studies with socio-technology, examining how digital environments, biomedical frameworks, workplace structures, and mobility patterns shape the experiences and well-being of diverse populations. She has led and contributed to influential research on sex and gender perspectives in clinical practice, inequalities in health systems, digital culture, feminist technoscience, and gendered transformations in labour markets and academia. An active contributor to international projects, she has advanced knowledge on social determinants of health, psychosocial risks in academic institutions, feminist digital activism, and the implications of technological change for equality. Her scholarship includes a substantial body of publications in high-impact journals and multiple contributions to books addressing gender, leadership, social research methodologies, and contemporary social challenges. She has supervised doctoral research on gender, ICT, care practices, and women’s empowerment, strengthening the next generation of feminist scholarship. Her professional experience includes leadership roles in scientific associations, editorial responsibilities in respected sociology journals, and participation in expert committees shaping the field of gender studies. Through interdisciplinary collaborations, research leadership, and public engagement, she has contributed to advancing equitable scientific practices, enriching sociological theory, and informing policies aimed at reducing gendered inequalities in health, technology, and knowledge production.

Profiles: Scopus | Orcid

Featured Publications

González Ramos, A. M., Serrano del Rosal, R., & Padrón, A. G. (2025). Gender regimes influences on social perception of pain and illness among European citizens. European Sociological Association, Research Network 16 Sociology of Health & Medicine Mid-Term Conference: Health in the Anthropocene: Sociological Analysis, Reflections, and Implications.

González Ramos, A. M., Benazizi, I., & Toledo, A. (2025). Women in biomedical model: The case of the instruments of diagnosis and recommendations (CPG, Clinical Practice Guidelines). European Sociological Association, Research Network 16 Sociology of Health & Medicine Mid-Term Conference: Health in the Anthropocene: Sociological Analysis, Reflections, and Implications.

González Ramos, A. M. (2025). La cultura de la pornografía: del castillo a la pantalla. In La pornografía, un problema social global: Didáctica feminista (ISBN 978-84-1079-009-4). C.S.I.C.

Padrón Armas, A., González Ramos, A., & Serrano-del-Rosal, R. (2025). Understanding health and pain through the gender regime: A multilevel framework from a sociological view. Social Sciences, 14(11), Article 636.

González Ramos, A. M., Gavín Benavent, P., & Isern de Val, S. (2025). La incorporación de la perspectiva de sexo y género en las guías de práctica clínica. Revista Española de Salud Pública.

Yuchun Wei | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr. Yuchun Wei | Medicine and Health Sciences | Best Researcher Award

Shandong Cancer Hospital China

Dr. Yuchun Wei is a leading Chinese physician-scientist in the field of oncology and nuclear medicine, currently working at the Shandong Cancer Hospital in Jinan, China. Born on November 22, 1987, she has contributed significantly to developing innovative imaging techniques for cancer diagnosis, staging, and individualized treatment planning. With deep expertise in PET/CT imaging biomarkers, she is committed to advancing precision oncology. 📡🧬

Profile

Scopus

Orcid

🎓 Education

Dr. Wei pursued her academic journey with a strong foundation in both Western and traditional Chinese medicine:

  • Ph.D. in Oncology from Shandong University (2018–2022), mentored by Academician Jinming Yu 🎓
  • Master’s in Oncology from Jinan University (2013–2016), under Prof. Shuanghu Yuan 🔬
  • Bachelor’s in Traditional Chinese and Western Clinical Medicine from Shandong University of Traditional Chinese Medicine (2007–2012) 🌿

💼 Professional Experience

Dr. Wei currently serves as a radiotherapy physician at Shandong Cancer Hospital (2017–present). She has also held several administrative and research leadership roles:

  • Deputy Director, MDT Quality Management Office (2021–2022)
  • Assistant Director, Radioimmunity and Molecular Imaging Room (2020–2021)
    Her clinical expertise is complemented by her operational leadership in multidisciplinary cancer care. 🏥⚕️

🔬 Research Interests

Her research revolves around novel imaging techniques, especially FAPI-based PET/CT imaging, with a focus on early detection, prognosis prediction, and therapy monitoring for cancers such as lung, esophageal, and cervical. Her goal is to refine personalized cancer treatment through quantitative imaging biomarkers. 🔍📊

🏆 Awards & Honors

Dr. Wei has been nominated for multiple research and innovation awards in recognition of her work in molecular imaging and radiation oncology. Her studies have earned significant visibility in top-tier journals (JCR Q1), and she is regarded as a rising star in clinical translational imaging. 🌟

📚 Publications Top Notes: 

Dr. Wei has authored and co-authored over 17 high-impact peer-reviewed papers, most of which appear in JCR Q1 journals. Here are her key publications with direct links and citation highlights:

FAPI Compared with FDG PET/CT for Lung Cancer Diagnosis
Radiology, 2023, IF: 19.7 | Cited by: 33

18F-FAPI PET/CT in Esophageal SCC Response Prediction
J Nucl Med, 2024, IF: 9.1 | Cited by: 12

Early Detection of Radiation-Induced Myocardial Damage
Eur J Nucl Med Mol Imaging, 2023, IF: 10.057 | Cited by: 40

18F-FAPI PET/CT Response in Chemoradiotherapy for ESCC
J Nucl Med, 2023, IF: 11.082 | Cited by: 25

Biodistribution and Targeting of 18F-FAPI-04
Eur J Nucl Med Mol Imaging, 2022, IF: 10.057 | Cited by: 37

Differentiating Lung Cancer Types via PET/CT
Eur J Nucl Med Mol Imaging, 2022, IF: 10.057 | Cited by: 31

Baseline Angiogenesis in NSCLC Prognosis
J Transl Med, 2022, IF: 8.44 | Cited by: 19

Differentiating Inflammatory Lung Lesions with FAPI
Eur Radiol, 2023, IF: 5.9 | Cited by: 10

Comparison Study in Mouse Model using PET Imaging
Sci Rep, 2016, IF: 5.228 | Cited by: 50

Radiation-Induced Lung Damage Model in Rats
Front Oncol, 2022, IF: 5.738 | Cited by: 14